Mark Bower

20.1k total citations · 1 hit paper
340 papers, 11.3k citations indexed

About

Mark Bower is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Mark Bower has authored 340 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Oncology, 104 papers in Pathology and Forensic Medicine and 74 papers in Epidemiology. Recurrent topics in Mark Bower's work include Viral-associated cancers and disorders (169 papers), Lymphoma Diagnosis and Treatment (100 papers) and HIV/AIDS drug development and treatment (45 papers). Mark Bower is often cited by papers focused on Viral-associated cancers and disorders (169 papers), Lymphoma Diagnosis and Treatment (100 papers) and HIV/AIDS drug development and treatment (45 papers). Mark Bower collaborates with scholars based in United Kingdom, United States and Italy. Mark Bower's co-authors include Mark Nelson, Justin Stebbing, Brian Gazzard, Sundhiya Mandalia, E.S. Newlands, Tom Powles, Gordon Rustin, Tom Newsom‐Davis, Ashita Waterston and L. Holden and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mark Bower

330 papers receiving 11.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kaposi sarcoma

2019 402 citations Blossom Damania, Mark Bower et al. Nature Reviews Disease Primers profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Bower	6.1k	2.9k	2.8k	1.9k	1.6k	340	11.3k
Cynthia M. Magro	2.4k 0.4×	3.0k 1.1×	3.2k 1.1×	2.3k 1.2×	1.7k 1.1×	443	13.8k
Hermann Herbst	3.8k 0.6×	2.8k 1.0×	2.0k 0.7×	1.1k 0.6×	1.6k 1.0×	207	10.1k
John L. Ziegler	3.7k 0.6×	2.4k 0.8×	1.5k 0.5×	1.6k 0.8×	594 0.4×	140	7.8k
Susan E. Krown	3.7k 0.6×	1.5k 0.5×	1.3k 0.5×	712 0.4×	560 0.4×	129	6.2k
Ted Gooley	4.9k 0.8×	1.8k 0.6×	2.6k 0.9×	831 0.4×	1.1k 0.7×	322	18.3k
Michael A. Nalesnik	4.8k 0.8×	1.9k 0.7×	2.9k 1.0×	826 0.4×	3.7k 2.4×	220	12.7k
Charles S. Rabkin	3.9k 0.6×	1.8k 0.6×	2.1k 0.8×	749 0.4×	4.3k 2.8×	166	10.6k
Vincent T. DeVita	5.1k 0.8×	5.5k 1.9×	1.6k 0.6×	846 0.4×	1.7k 1.1×	191	14.2k
Alexandar Tzankov	5.0k 0.8×	3.3k 1.2×	1.0k 0.4×	4.0k 2.1×	1.3k 0.8×	379	16.0k
Rebecca Gelman	6.8k 1.1×	3.6k 1.3×	1.1k 0.4×	733 0.4×	2.4k 1.5×	223	16.1k

Countries citing papers authored by Mark Bower

Since Specialization

Citations

This map shows the geographic impact of Mark Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bower more than expected).

Fields of papers citing papers by Mark Bower

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bower. The network helps show where Mark Bower may publish in the future.

Co-authorship network of co-authors of Mark Bower

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bower. A scholar is included among the top collaborators of Mark Bower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bower. Mark Bower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fulgenzi, Claudia Angela Maria, Alessia Dalla Pria, Alberto Giovanni Leone, et al.. (2025). Hepatocellular carcinoma in people living with HIV. Journal of Hepatology. 83(4). 971–981.

Carbone, Antonino, et al.. (2025). Management of KSHV/HHV8-Positive Multicentric Castleman Disease Concurrent With Other KSHV/HHV8-Positive Disorders: An Emergent Challenge in PLWH. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(1). e1–e2.

Carbone, Antonino, et al.. (2024). Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management. Blood Reviews. 64. 101167–101167. 4 indexed citations

Berner, Alison, et al.. (2024). UK Cancer and Transition Service (UCATS): Providing tailored cancer care to the gender-diverse community.. Journal of Clinical Oncology. 42(16_suppl). e13676–e13676. 1 indexed citations

Berner, Alison, et al.. (2023). 265P UCATS: A national specialist service for integration of gender affirming and oncological care in transgender patients with breast cancer. ESMO Open. 8(1). 101361–101361.

Cortellini, Alessio, Ramón Salazar, Mark Bower, et al.. (2022). Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer. British Journal of Cancer. 127(10). 1787–1792. 5 indexed citations

Bower, Mark & Antonino Carbone. (2021). KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV. SHILAP Revista de lepidopterología. 2(4). 703–712. 7 indexed citations

Hentrich, Marcus, Mark Bower, Gedske Daugaard, et al.. (2021). Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. Cancer. 128(2). 260–268. 2 indexed citations

Carbone, Antonino, Margaret Borok, Blossom Damania, et al.. (2021). Castleman disease. Nature Reviews Disease Primers. 7(1). 96 indexed citations

10.

Gramolelli, Silvia, Thomas Günther, Seppo Kaijalainen, et al.. (2020). Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production. Cancer Research. 80(15). 3116–3129. 16 indexed citations

11.

Hill, Andrew, Dzintars Gotham, Joseph Fortunak, et al.. (2016). Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment. BMJ Open. 6(1). e009586–e009586. 46 indexed citations

12.

Gregson, John, Leticia Kuri-Cervantes, Christopher M. Mela, et al.. (2012). Short Communication: NKG2C ⁺ NK Cells Contribute to Increases in CD16 ⁺ CD56 ⁻ Cells in HIV Type 1 ⁺ Individuals with High Plasma Viral Load. AIDS Research and Human Retroviruses. 29(1). 84–88. 15 indexed citations

13.

Kuri-Cervantes, Leticia, et al.. (2012). PD-1 Expression on Natural Killer Cells and CD8 ⁺ T Cells During Chronic HIV-1 Infection. Viral Immunology. 25(4). 329–332. 90 indexed citations

14.

Sita-Lumsden, Ailsa, et al.. (2010). Lymphoma in the immunocompromised. British Journal of Hospital Medicine. 71(5). 264–268. 2 indexed citations

15.

Powles, Thomas, David Robinson, Justin Stebbing, et al.. (2008). Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection. Journal of Clinical Oncology. 27(6). 884–890. 269 indexed citations

16.

Stebbing, Justin, Simon Portsmouth, & Mark Bower. (2003). Insights into the molecular biology and sero-epidemiology of Kaposiʼs sarcoma. Current Opinion in Infectious Diseases. 16(1). 25–31. 24 indexed citations

17.

Brock, C., E.S. Newlands, Stephen R. Wedge, et al.. (1998). Phase I trial of temozolomide using an extended continuous oral schedule.. PubMed. 58(19). 4363–7. 228 indexed citations

18.

Bower, Mark, et al.. (1994). Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment.. PubMed. 8(2). 226–9. 18 indexed citations

19.

Mahalanobis, Abhijit, et al.. (1993). A Quadratic Distance Classifier for Multi-Class SAR ATR using Correlation Filters.. Proc SPIE. 1875. 84–95. 6 indexed citations

20.

Bower, Mark, et al.. (1991). The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy. Cancer Chemotherapy and Pharmacology. 28(4). 311–312. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact